Strategic partnerships FHC has ongoing collaboration activity with other tech and medical device companies (e.g., Avrio MedTech for SEEG software) and acquisitions/brand integration with Neuralynx, indicating fertile ground for channel partnerships, distribution deals, and co-development opportunities to expand market reach.

Product velocity Frequent product launches and software tools (NLX-PyIO 1.0, STarFix Designer, N-Form) show a strong cadence of new offerings, suggesting cross-sell and upsell opportunities for laboratories and clinics adopting modular, interoperable electrophysiology solutions.

End-to-end solutions Neuralynx/FHC provides hardware, software, and experiment accessories for neuroscience research and human data recording, presenting a holistic value proposition to customers. This enables sales moves tied to bundled offerings and long-term service contracts.

Industry credibility Recognition as a best place to work and long-standing history in electrophysiology with ISO/medical compliance signals reliability. This can be leveraged to win procurement decisions in risk-averse institutions seeking compliant, proven partners.

SMB-focused expansion Company size and revenue range indicate a target sweet spot in small to mid-sized neuro research labs and clinics. There are opportunities to tailor scalable packages, training, and support to growing institutions looking to upgrade data acquisition and analysis capabilities.